Bisphosphonates: mechanism of action and role in clinical practice - Wikidata - wikimedia - TriplyDB

Bisphosphonates: mechanism of action and role in clinical practice

Bisphosphonates: mechanism of action and role in clinical practice

http://www.wikidata.org/entity/Q24644708

about

Bisphosphonates in multiple myeloma: a network meta-analysis Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy Bisphosphonates for osteoarthritis Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review Clinical practice. Primary ovarian insufficiency A new approach to primary ovarian insufficiency Dental complications and management of patients on bisphosphonate therapy: A review article Targeted microbubbles: a novel application for the treatment of kidney stones.Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis Synthesis of composite magnetic nanoparticles Fe3O4 with alendronate for osteoporosis treatment A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency Blood flow controls bone vascular function and osteogenesis.Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.Can denosumab be a substitute, competitor, or complement to bisphosphonates?Total hip arthroplasty in patients with Paget's disease of bone: A systematic review.Association between alendronate and atypical femur fractures: a meta-analysis.Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.Atypical femoral fractures mimicking metastatic lesions in 2 patients taking denosumab.Estrogen depletion and drug treatment alter the microstructure of type I collagen in bone.Administration of RANKL boosts thymic regeneration upon bone marrow transplantation Direct antitumour activity of zoledronic acid: preclinical and clinical data.Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics Bone disease in multiple myeloma: pathophysiology and management.Bone cancer pain.Effect of bisphosphonates on the progression of degenerative aortic stenosis.Aging, human immunodeficiency virus, and bone health.Emerging therapeutic opportunities for skeletal restoration.Osteoporosis and gastrointestinal disease.Bisphosphonate remains highly localized after elution from porous implants Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?Bisphosphonates pathway.Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis.Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.Osteoporosis in chronic obstructive pulmonary disease

P2860

Q24197839-296BE66D-F35E-4AAD-B0EB-A6C048F01F16 Q24198280-34F6F8A7-6141-43BC-B197-B9C0C0CF3882 Q24202794-E501CD21-98DE-40D0-AEEC-8FD653D10DB9 Q24597422-DDEC77C2-DC14-4D26-B774-5DA851A5D201 Q24653014-266D3757-CD63-4241-8A2A-80C665F538F7 Q26859812-D9D104F5-0EE3-42F7-BEFF-0B7E470D7844 Q27022492-A51D019C-4CAB-4298-81F1-62BAC7643DFF Q27030812-A1E00784-2C4C-4A47-BE5D-6003426714DE Q28481154-47C2EA6B-7815-45F7-89C6-9EFA727A5617 Q28829845-FBD9149B-6923-4C56-842C-F0EBCDFDD7FD Q28972322-DD188F8B-D44E-4FF0-890B-BDC5362B235B Q30831553-D795874F-D5F4-4BE1-B564-5DD57AF71544 Q31108809-023C93E9-7244-4FB5-86F7-EAE9054F39BB Q31156585-11BE97B5-B23E-4B7B-9211-0762F7C0B76E Q33567830-B527DF81-A2C0-42C3-BABD-2FEFF8E3198D Q33577356-EB777324-B1A4-4407-A36A-5EF6FE4BA6AF Q33596535-E3B0133D-1C62-4E1A-8444-EBB8E6075963 Q33665130-7DC6893E-3902-4C17-95F9-41052273F3F4 Q33697117-B439E0C9-CEAA-4DB1-9387-C91FAA39FC16 Q33716919-A36612E4-5989-4AA7-8C12-9824B9D81345 Q33748998-DE44C734-BFC9-46C5-B668-770BDD919FFF Q33850938-C5BF0DC0-34FD-48BD-B14D-49A06318FF85 Q33898842-9F5114A2-13BB-47E2-8C54-E2BDF85C4175 Q33958113-7A600697-CCFF-44D8-8B33-450D93A2986D Q34025648-DC08EBD6-2159-4830-AAB0-66134FC52FEC Q34038854-33D66CB5-D760-44B3-AB89-0FF3C104824B Q34045789-2A43DF2B-D081-4308-8AB3-D51DC8ECE30C Q34120101-351B0F49-4F4E-442E-A708-448AEA59F96F Q34129152-C7450860-E35F-4428-A814-E03E6F5B52EA Q34160511-21208F0A-0C4A-44C3-A0B1-3FD47FE6E2D0 Q34161867-0AFCCB94-0594-41F1-9D5F-CFBEB3D20E17 Q34178759-1D4A6E55-6EAC-46F9-B470-87D89F5C5D4C Q34477058-F892E5E1-4582-4AE8-8446-1239F2A7F903 Q34599958-43F24124-38A1-47B3-9D83-92D92F6F2971 Q34753158-A8AB6801-788B-46AA-B2B3-05233B89268A Q34905878-0FD6AE0C-1CE4-42EC-846A-E65CB5A5562F Q35068631-97107481-A169-430A-BE68-D9D7D8C97B5D Q35112085-1A9D9EF8-52CB-43A4-A0BE-2382DDD55963 Q35157851-7376DDDF-CD26-4647-92F0-513612D41149 Q35173349-98C3B252-8E22-40D4-9190-E4BE23D1A5C0

P2860

Bisphosphonates: mechanism of action and role in clinical practice

http://www.wikidata.org/entity/Q24644708

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Bisphosphonates: mechanism of action and role in clinical practice

@ast

Bisphosphonates: mechanism of action and role in clinical practice

@en

Bisphosphonates: mechanism of action and role in clinical practice

@nl

type

label

Bisphosphonates: mechanism of action and role in clinical practice

@ast

Bisphosphonates: mechanism of action and role in clinical practice

@en

Bisphosphonates: mechanism of action and role in clinical practice

@nl

prefLabel

Bisphosphonates: mechanism of action and role in clinical practice

@ast

Bisphosphonates: mechanism of action and role in clinical practice

@en

Bisphosphonates: mechanism of action and role in clinical practice

@nl

P1433

Q24644708-097E6212-3C17-494E-8542-FFF8B9A76A4A

P1476

Q24644708-65605688-2728-472A-854A-D1B749569814

P2093

Q24644708-1D13275C-5090-4322-B536-36C3DFF1CEA1

Q24644708-7CC14CAC-33F4-46A3-A8DC-B84A3AD155AD

P2860

Q24644708-003A23EC-8A67-4CDC-B333-5D32592224CE

Q24644708-0126FAEF-D967-4CB3-A700-D4673D91A2C7

Q24644708-075D8516-AD0C-4C99-A4D8-16CEE544A0C7

Q24644708-099763BC-57A1-4611-B6AB-0DE1567FDE3D

Q24644708-0A35912D-C2C3-49BF-88DD-3F1F351D100E

Q24644708-0B62F45B-BE24-4A83-BF78-1015F284AFBF

Q24644708-0CBB3341-A071-4903-8F67-63160787FACA

Q24644708-0FD9A2F9-484F-4201-B279-4225E5FBAC7F

Q24644708-128615A9-93AA-4E3F-99F3-182A88BB55BB

Q24644708-15A2D816-9395-48FE-88D3-47EB9F79D8EB

P304

Q24644708-FEC6D174-CD8E-4804-8439-C174E3F64B0E

P31

Q24644708-54F87488-00A1-4421-BE91-EDC693B3805A

Q24644708-e8940e44-9753-4eb8-93f4-eb1a9dbb101e

P3181

Q24644708-2734A692-FB59-466D-99DF-7653DB7E0A4C

P356

Q24644708-A9A04FCA-A946-45C7-B476-0B2140D3F807

P407

Q24644708-BBD320D0-BDB1-4B93-8E62-0910AE7E270D

P433

Q24644708-C3E88B45-06D0-41EB-B7F2-D909CBB45995

P478

Q24644708-EC67199B-B2AF-4AAC-AAD6-530E343B6CC6

P50

Q24644708-3268A2E7-4F96-4AB5-B4EE-5D281A660A22

P577

Q24644708-4417BCEB-D304-4DA8-A0C6-0C729FD2C616

P5875

Q24644708-FB83D1ED-4348-436B-945D-5C2A9173F421

P698

Q24644708-11260D86-5FBA-4BBD-B85C-45FB54A6E2DA

P932

Q24644708-13E4C577-B2FE-4A59-9647-73A8DA13FB6F

P3181

P356

P1433

Mayo Clinic Proceedings

P1476

Bisphosphonates: mechanism of action and role in clinical practice

@en

P2093

Bart L Clarke

http://www.w3.org/2001/XMLSchema#string

Matthew T Drake

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate therapy for children and adolescents with secondary osteoporosis

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

Rho GTPases and the actin cytoskeleton

Vitamin D deficiency

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

Bisphosphonates: from bench to bedside

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

P304

1032-1045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

317634

http://www.w3.org/2001/XMLSchema#string

P356

10.4065/83.9.1032

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23241189

http://www.w3.org/2001/XMLSchema#string

P698

18775204

http://www.w3.org/2001/XMLSchema#string

P932

2667901

http://www.w3.org/2001/XMLSchema#string